TitleDevelopment of secondary inclusions in cells infected by Chlamydia trachomatis.
Publication TypeJournal Article
Year of Publication2005
AuthorsSuchland, RJ, Rockey, DD, Weeks, SK, Alzhanov, DT, Stamm, WE
JournalInfect Immun
Volume73
Issue7
Pagination3954-62
Date Published2005 Jul
ISSN0019-9567
KeywordsBacterial Proteins, Chlamydia trachomatis, Humans, Inclusion Bodies, Membrane Proteins, Vacuoles
Abstract

The chlamydiae are obligate intracellular bacteria that occupy a non-acidified vacuole (the inclusion) during their entire developmental cycle. These bacteria produce a set of proteins (Inc proteins) that localize to the surface of the inclusion within infected cells. Chlamydia trachomatis IncA is also commonly found in long fibers that extend away from the inclusion. We used standard and confocal immunofluorescence microscopy to demonstrate that these fibers extend to newly developed inclusions, termed secondary inclusions, within infected cells. Secondary inclusions observed at early time points postinfection were devoid of chlamydial reticulate bodies. Later in the developmental cycle, secondary inclusions containing variable numbers of reticulate bodies were common. Reticulate bodies were also observed within the IncA-laden fibers connecting primary and secondary inclusions. Quantitative differences in secondary inclusion formation were found among clinical isolates, and these differences were associated with serovar. Isolates of serovar G consistently produced secondary inclusions at the highest frequency (P < 0.0001). Similar quantitative studies demonstrated that secondary inclusion formation was associated with segregation of inclusions to daughter cells following cytokinesis. We conclude that the production of secondary inclusions via IncA-laden fibers allows chlamydiae to generate an expanded intracellular niche in which they can grow and may provide a means for continuous infection within progeny cells following cell division.

DOI10.1128/IAI.73.7.3954-3962.2005
Alternate JournalInfect Immun
PubMed ID15972482
PubMed Central IDPMC1168544
Grant ListU19 AI031448 / AI / NIAID NIH HHS / United States
R01 AI048769 / AI / NIAID NIH HHS / United States
AI42869 / AI / NIAID NIH HHS / United States
AI31448 / AI / NIAID NIH HHS / United States
AI48769 / AI / NIAID NIH HHS / United States